In a filing, ClearPoint Neuro Inc revealed its Director Richards Timothy T. unloaded Company’s shares for reported $0.13 million on Jun 10 ’25. In the deal valued at $13.28 per share,10,000 shares were sold. As a result of this transaction, Richards Timothy T. now holds 77,381 shares worth roughly $0.86 million.
Then, BURNETT JOSEPH sold 21,247 shares, generating $282,373 in total proceeds. Upon selling the shares at $13.29, the CEO and President now owns 243,522 shares.
Before that, TIMOTHY RICHARDS bought 10,000 shares. ClearPoint Neuro Inc shares valued at $132,843 were divested by the Director at a price of $13.28 per share.
A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating.
Price Performance Review of CLPT
On Tuesday, ClearPoint Neuro Inc [NASDAQ:CLPT] saw its stock fall -5.91% to $11.15. Over the last five days, the stock has lost -5.19%. ClearPoint Neuro Inc shares have risen nearly 45.56% since the year began. Nevertheless, the stocks have fallen -27.50% over the past one year. While a 52-week high of $19.22 was reached on 02/06/25, a 52-week low of $6.25 was recorded on 04/07/25.
Levels Of Support And Resistance For CLPT Stock
The 24-hour chart illustrates a support level at 10.72, which if violated will result in even more drops to 10.30. On the upside, there is a resistance level at 11.76. A further resistance level may holdings at 12.38.
How much short interest is there in ClearPoint Neuro Inc?
A steep rise in short interest was recorded in ClearPoint Neuro Inc stocks on 2025-06-13, dropping by 18459.0 shares to a total of 1.19 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 1.21 million shares. There was a decline of -1.55%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 18, 2021 when Lake Street began covering the stock and recommended ‘”a Buy”‘ rating along with a $32 price target.
